You are here

Onureg

Bristol Myers Squibb can grow through Revlimid generics, execs insist, pointing to key launches

Fierce Pharma

Thu, 02/4/21 - 08:15 pm

Bristol-Myers Squibb

Bristol Myers Squibb execs tout progress on Zeposia, Reblozyl and Onureg launches

Fierce Pharma

Fri, 11/6/20 - 12:38 am

Bristol-Myers Squibb

FDA approves Onureg as continued treatment for adults in first remission with AML

Pharmaceutical Business Review

Wed, 09/2/20 - 10:37 am

Bristol-Myers Squibb